Peter Attia MD229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB
Episode Details
EPISODE INFO
- Released
- October 31, 2022
- Duration
- 1h 18m
- Channel
- Peter Attia MD
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
Watch the full episode and view show notes here: https://bit.ly/3FwAC0p Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ In this special episode of The Drive, we have pulled together a variety of clips from previous podcasts about cardiovascular disease to help listeners understand this topic more deeply, as well as to identify previous episodes which may be of interest. In this episode, Peter highlights the importance of understanding cardiovascular disease and why early intervention is critical. He also provides a primer on lipoproteins and explains the fallacy of the terms “good cholesterol” and “bad cholesterol.” Allan Sniderman discusses the metrics measured in routine blood work – along with the limitations of those standard panels – before explaining why apoB is a superior metric for determining risk. Additionally, Tom Dayspring explains the casual role of apoB in atherosclerotic cardiovascular disease (ASCVD) and the therapeutic goals for apoB concentration, and Peter explains how early and aggressive lowering of apoB could change the landscape of cardiovascular disease prevention. We discuss: -Intro [0:00] -The importance of understanding atherosclerosis early in life [2:25]; -Defining ASCVD, its causes, and the role of cholesterol [8:00]; -Why early prevention of atherosclerosis is critical [13:45]; -Preventing atherosclerosis—two fatal flaws with the “10-Year Risk” approach [16:00]; -Intro to lipids and lipoproteins: why there is no “bad” or “good” cholesterol [23:00]; -Limitations of standard blood panels [35:45]; -How Mendelian randomization is bolstering the case for apoB as the superior metric for risk prediction [39:30]; -Therapeutic goals for apoB concentration [58:15]; -How early and aggressive lowering of apoB could change the course of ASCVD [1:10:45]; and -More. -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 45 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies.
SPEAKERS
Peter Attia
hostPhysician and host of The Drive podcast, focused on longevity and cardiovascular disease prevention.
Allan Sniderman
cameoCardiologist and lipid researcher known for seminal work on apoB and atherosclerotic cardiovascular disease risk.
Tom Dayspring
cameoLipidology expert known for clinical education on apoB, lipoproteins, and ASCVD risk.
EPISODE SUMMARY
In this episode of Peter Attia MD, featuring Peter Attia and Allan Sniderman, 229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB explores why ApoB, Not 'Good' or 'Bad' Cholesterol, Drives Heart Disease Peter Attia argues atherosclerosis is the one inevitable disease of our species, that it starts decades before clinical events, and that first heart attacks are often fatal, so prevention must begin early.
RELATED EPISODES
